Brexit
Attracting the Best Life Sciences Talent After Brexit
One of the reasons that the UK is a leader in life sciences has been its ability to attract, develop and retain a highly...
Brexit’s Uncertainty Principle
While the minutiae of the possible upcoming permutations for drug supply depending on various Brexit outcomes have been written about elsewhere, less thought has been...
Does the European Medicines Agency’s move to Amsterdam presage a brain drain from the UK?
Last week’s long-awaited announcement of the new home for the European Medicines Agency (EMA), from March 2019, puts the big question behind us but...
The UK is a leader in life sciences. How can we make sure that it remains No.1 in Europe?
After spending a day in mid-October at this year’s excellent UK BioScience Forum, I was left with one particular thought ringing loud and clear...
A Report from BIO-Europe Spring 2017
The blue skies and balmy weather of Barcelona were the perfect backdrop for BIO-Europe Spring this year. The 2,400 biotech pros at the conference...
Shaping up for growth in a world of change
The 34th FT Global Pharmaceutical and Biotechnology Conference brought together life science and pharma companies as well as emerging new players. Discussions centered on industry challenges,...
Change for the better
Talent is more global now than ever. In light of the recent Brexit vote and the fact that demand for talent in Europe is...